Breast Cancer Res Treat. 2018 Mar 13. doi: 10.1007/s10549-018-4746-6. [Epub ahead of print]
Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011.
Adjuvant; Biomarkers; Breast neoplasms; Chemotherapy; Gene expression profiling; Genetic testing; Physicians’; Practice patterns; SEER program; Tumor